Fighting cancer wasting: can diet and exercise make olanzapine work better?

NCT ID NCT07722806

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether adding a structured nutrition and exercise program to the standard appetite-stimulating drug olanzapine can improve quality of life in people with advanced solid tumors who have poor appetite. Participants are randomly assigned to receive olanzapine alone or olanzapine plus personalized dietary advice, exercise sessions, and a protein supplement. The study tracks quality of life, fatigue, and nutritional status over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
olanzapine plus a standardized nutrition and exercise program
What this could lead to
If it works, this could point toward a better way to manage appetite loss and malnutrition in advanced cancer, potentially improving quality of life.
What could go wrong
This is a mid-stage trial with 130 participants, so results may not apply to all cancer patients. The added program requires time and effort, and olanzapine can cause side effects like drowsiness or weight gain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER, ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kantonsspital Winterthur

    Winterthur, 8401, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.